SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: dan oreilly who wrote (56889)7/28/2000 11:35:20 AM
From: Tom Allinder  Read Replies (1) | Respond to of 150070
 
DNAP/PATH... It is hard to compare stocks... easier to tell you what DNAP is doing. DNAP is using a method similar to the "treat the cause, not the symptom"... DNAP is forming solutions

There is much good reading at:

dnaprint.com

Tom



To: dan oreilly who wrote (56889)7/28/2000 11:43:47 AM
From: y2kfree_radical  Respond to of 150070
 
PATH-is in my profession,i.e.,clinical & surgical pathology--it is supplying raw material,blood samples,to genomic companies.I,and others,will do the same for DNAP.There is little comparison between the two business models as PATH is a more mature commodity play while DNAP is a true R&D biotech firm


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News